UBE2E2
Ubiquitin-conjugating enzyme E2 E2
Also known as: FLJ25157, UB2E2_HUMAN, UbcH8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96LR5
- Gene
- UBE2E2
- Ensembl
- ENSG00000182247
- Chromosome
- 3
- Canonical length
- 201 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables ISG15 transferase activity and ubiquitin conjugating enzyme activity. Involved in protein modification by small protein conjugation. Acts upstream of or within DNA damage response and positive regulation of G1/S transition of mitotic cell cycle. Predicted to be active in nucleus. Implicated in type 2 diabetes mellitus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
201 residues, UniProt reviewed canonical sequence.
>Q96LR5|UBE2E2
1 MSTEAQRVDD SPSTSGGSSD GDQRESVQQE PEREQVQPKK KEGKISSKTA AKLSTSAKRI
61 QKELAEITLD PPPNCSAGPK GDNIYEWRST ILGPPGSVYE GGVFFLDITF SPDYPFKPPK
121 VTFRTRIYHC NINSQGVICL DILKDNWSPA LTISKVLLSI CSLLTDCNPA DPLVGSIATQ
181 YMTNRAEHDR MARQWTKRYA TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2E2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 39 nTPM
- cerebral cortex: 27 nTPM
- epididymis: 24 nTPM
- adipose tissue: 23 nTPM
- ovary: 21 nTPM
- hypothalamus: 20 nTPM
Single-cell type
- myonuclei: 1,644 nCPM
- microglia: 1,418 nCPM
- adipocytes: 1,165 nCPM
- gonadotrophs: 1,033 nCPM
- thymic myoid cells: 965 nCPM
- oligodendrocytes: 963 nCPM
Immune cell
- plasmacytoid DC: 74 nTPM
- myeloid DC: 58 nTPM
- non-classical monocyte: 55 nTPM
- intermediate monocyte: 51 nTPM
- classical monocyte: 42 nTPM
- naive B-cell: 40 nTPM
Brain region
- white matter: 65 nTPM
- cerebral cortex: 54 nTPM
- hippocampal formation: 45 nTPM
- basal ganglia: 43 nTPM
- hypothalamus: 43 nTPM
- cerebellum: 38 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about UBE2E2.
Disease | ImmuneIEDB
Conditions an epitope on UBE2E2 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 2.29
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA damage response
- ISG15-protein conjugation
- positive regulation of G1/S transition of mitotic cell cycle
- protein K11-linked ubiquitination
- protein K48-linked ubiquitination
- protein K63-linked ubiquitination
- protein monoubiquitination
Molecular functions
- ATP binding
- ISG15 transferase activity
- ubiquitin conjugating enzyme activity
- ubiquitin-protein transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2E2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2E2 as an antibody target. Whether an autoantibody or antibody against UBE2E2 could matter depends on whether native UBE2E2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2E2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2E2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...